IL6 and COVID-19: An increase in CSF levels of IL-4, IL-8, IL-10 and/or IL-17 has been previously described in sCJD cases [8–10]; however, a pattern that includes increased IL-6 and IL-8 has been specifically observed during the COVID-19 pandemic [11].